Data Visualization

Data Visualization
Updated Jan. 11, 2021

COVID-NET

March 1, – November 28, 2020

Weekly COVID-19-associated hospitalization rates are at their highest since the beginning of the pandemic.

Additional COVID-NET hospitalization data, including rates for different age groups and by surveillance site, are available on the COVID-NET interactive data page.

COVID Net Hospitalizations 12-14-2020

COVIDView

Additional COVIDView surveillance data for U.S. COVID-19 activity are available on the COVIDView page.

MMWR Reports

January 1, 2021

Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020

Compared with real-time reverse transcription–polymerase chain reaction (RT-PCR) testing, the Sofia antigen test had a sensitivity of 80.0% and specificity of 98.9% among symptomatic persons; accuracy was lower (sensitivity 41.2% and specificity 98.4%) when used for screening of asymptomatic persons.

Read the full report.

COVID-19 rapid tests are inexpensive and fast but sometimes give incorrect results

View previous graphics from MMWR

Other Publications

July 23, 2020

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

A recently published study identified 186 cases of multisystem inflammatory syndrome in children (MIS-C) across pediatric health centers in 26 states from March through May, 2020. Read the study online: https://www.nejm.org/doi/full/10.1056/NEJMoa2021680external iconexternal icon

July 6, 2020

What COVID-19 Seroprevalence Surveys Can Tell Us

Seroprevalence surveys are investigations that involve the use of serology test (also known as antibody tests) to better understand how many SARS-CoV-2 infections have occurred at different points in time, in different locations, and in different populations in the United States.
external iconexternal icon

July 1, 2020

Percentage of Population Positive for SARS-CoV-2 Antibodies in Samples from Areas in 6 States

​CDC is partnering with commercial laboratories to conduct a large-scale geographic seroprevalence survey that has tested de-identified clinical blood specimens from 6 sites. Read more about this survey: Commercial Laboratory Seroprevalence Surveys

Percentage of Population Positive for SARS-CoV-2 Antibodies in Samples from Areas in 6 States

Archived COVIDView Graphics

Archived COVID-NET Graphics

Archived MMWR Report Graphics